Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
In connection with the IPO, on May 9, 2022, Dean Clinton, Kunal Bahl, Girish Vanvari, Ashwini Asokan, Manpreet Singh (collectively, the “Directors”) were appointed to the board of directors of the Company (the “Board”). The Board has determined that Messrs. Bahl, Singh and Vanvari and Ms. Asokan are independent directors within the meaning of applicable SEC and Nasdaq rules. Effective May 9, 2022, Mr. Vanvari, Ms. Asokan and Mr. Singh will serve on the Audit Committee and Mr. Singh will serve as chair. Mr. Bahl, Ms. Asokan and Mr. Singh will serve on the compensation committee and Mr. Bahl will serve as chair of the compensation committee. Mr. Bahl, Ms. Asokan and Mr. Singh will serve on the nominating and corporate governance committee and Mr. Bahl will serve as chair of the nominating and corporate governance committee.
On May 9, 2022, in connection with his appointment to the Board, each Director entered into the Letter Agreement as well as an Indemnity Agreement with the Company in the form previously filed as Exhibit 10.5 to the Registration Statement.
Other than the foregoing, none of the Directors are party to any arrangement or understanding with any person pursuant to which they were appointed as directors, nor are they party to any transactions required to be disclosed under Item 404(a) of Regulation S-K involving the Company.
The foregoing descriptions of the Letter Agreement and the form of Indemnity Agreement do not purport to be complete and are qualified in their entireties by reference to the Letter Agreement and form of indemnity agreement, copies of which are attached as Exhibit 10.1 hereto and Exhibit 10.5 to the Registration Statement, respectively, and are incorporated herein by reference.
Item 5.03. Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.
On May 9, 2022, in connection with the IPO, the Company adopted its Amended and Restated Memorandum and Articles of Association (the “Amended Charter”), effective the same day. The terms of the Amended Charter are set forth in the Registration Statement and are incorporated herein by reference. A copy of the Amended Charter is attached as Exhibit 3.2 hereto and incorporated herein by reference.
Item 8.01. Other Events.
A total of $266,512,500 of the proceeds from the IPO and the sale of the Private Placement Warrants were placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A. maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its taxes and up to $100,000 of interest to pay dissolution expenses, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of any of the Class A Ordinary Shares included in the Units sold in the IPO (the “public shares”) properly submitted in connection with a shareholder vote to amend the Company’s Amended Charter (A) to modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if it does not complete its initial business combination within 15 months (or up to 21 months if the Company extends the period of time to consummate a Business Combination) from the closing of the IPO or (B) with respect to any other material provisions relating to shareholders’ rights or pre-initial business combination activity or (iii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within 21 months from the closing of the IPO, subject to applicable law.
On May 9, 2022, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.
On May 12, 2022, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K.